LMR Partners’s Achieve Life Sciences ACHV Stock Holding History

LMR Partners’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-14	Closed	-$119K	–	323
2014 Q2	$119K	Buy	+14	New	+$172K	0.01%	429

Other funds holding ACHV

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

LMR Partners's ACHV Position: Q3 2014 in Review

LMR Partners sold out of Achieve Life Sciences (ACHV) in Q3 2014, closing a stake of 14 shares — an estimated $119K sold.

LMR Partners first reported a position in ACHV in Q2 2014 and held it in 1 quarter. The position peaked at $119K in Q2 2014. 52 funds tracked by Wall St. Rank hold ACHV as of Q3 2014.

LMR Partners reported no remaining Achieve Life Sciences position as of Q3 2014 after selling out during the quarter.
LMR Partners sold 14 Achieve Life Sciences shares in Q3 2014, an estimated $119K.
LMR Partners first reported a position in Achieve Life Sciences in Q2 2014 and held it in 1 quarter.
LMR Partners's Achieve Life Sciences position peaked at $119K in Q2 2014.
52 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2014.

Based on LMR Partners's 13F filing for Q3 2014, filed 20 Oct 2014.